Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neuroectodermal Tumors, Primitive, Peripheral 2Wilms Tumor 1Unspecified Adult Solid Tumor, Protocol Specific 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Optic Nerve Glioma 1Neuroblastoma 1Medulloblastoma 1Familial ependymoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Irinotecan 16Paclitaxel 14Docetaxel 13Gemcitabine 12Cisplatin 12Capecitabine 8Oxaliplatin 7Temozolomide 6Leucovorin 6Fluorouracil 6Carboplatin 6Topotecan 5Chromatography, High Pressure Liquid 5Polymerase Chain Reaction 4Pharmacogenomic Testing 4Pemetrexed 4Immunohistochemistry 4Filgrastim 4Everolimus 4Etoposide 4Early Intervention, Educational 4Celecoxib 4tipifarnib 3ixabepilone 3bryostatin 1 3Tegafur 3Sorafenib 3Mass Spectrometry 3Magnetic Resonance Spectroscopy 3Lapatinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Unspecified Adult Solid Tumor, Protocol Specific × trioctyl phosphine oxide × Clear all
NCT00541359 2017-08-09

Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors

City of Hope Medical Center

Phase 1 Completed
54 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡